NASDAQ:TRVI

Trevi Therapeutics Stock Forecast

etoro logo Buy TRVI
*Your capital is at risk
$18.65
+0.0200 (+0.107%)
At Close: Jun 30, 2026
AI Analysis AI Analysis of TRVI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TRVI to Watchlist?
Some Reasons Why To Add TRVI:
  • +227.2% price growth over the last year
  • +56.9% YTD performance
  • Low bankruptcy risk (Altman Z-Score: 204.35)
PDF

Green day on Tuesday for Trevi Therapeutics Inc.
(Updated on Jun 30, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 12, 2026 Gain 31.25%

The Trevi Therapeutics Inc. stock price gained 0.107% on the last trading day (Tuesday, 30th Jun 2026), rising from $18.63 to $18.65. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.59% from a day low at $18.41 to a day high of $19.26. The price has risen in 9 of the last 10 days and is up by 27.22% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 299 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $57.87 million.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $18.08, a level that may pose a second chance to hit a runner. According to fan-theory $21.96 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

TRVI Signals & Forecast

The Trevi Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $18.01 and $15.04. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 39.91%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Trevi Therapeutics Inc. stock

Trevi Therapeutics Inc. finds support from accumulated volume at $18.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.85 between high and low, or 4.59%. For the last week, the stock has had daily average volatility of 4.61%.

The Trevi Therapeutics Inc. stock is extremely overbought on RSI14 (91). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $18.06 (-3.18%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 91 and this increases the risk substantially. There is a buy signal from a pivot bottom found 16 days ago.)

Trading Expectations (TRVI) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Trevi Therapeutics Inc. to open at $18.77, and during the day (based on 14 day Average True Range), to move between $18.24 and $19.06, which gives a possible trading interval of +/-$0.82 (+/-4.50%) up or down from last closing price. If Trevi Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.50% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $18.15, some $0.500 (2.68%) from the current price of $18.65, our system finds the risk reward attractive.

Is Trevi Therapeutics Inc. stock A Buy?

Trevi Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 1, 2026 - $18.77 ( 0.669%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TRVI Performance

Trading levels for TRVI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 19.62 5.20%
R2 19.30 3.47%
R1 19.10 2.40%
Price 18.65
S1 18.45 -1.06%
S2 18.25 -2.13%
S3 17.93 -3.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 18.65
S1 18.15 -2.68%
S2 15.40 -17.43%
S3 15.23 -18.34%

FAQ

What is the symbol for Trevi Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Trevi Therapeutics Inc. is TRVI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Trevi Therapeutics Inc. Stock?
Trevi Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Trevi Therapeutics Inc. Stock?
Trevi Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Trevi Therapeutics Inc. Stock.

What's the current price of Trevi Therapeutics Inc. Stock?
As of the end of day on the Jun 30, 2026, the price of an Trevi Therapeutics Inc. (TRVI) share was $18.65.

What is the 52-week high and low for Trevi Therapeutics Inc. Stock?
The 52-week high for Trevi Therapeutics Inc. Stock is $19.26 and the 52-week low is $5.42.

What is the market capitalization of Trevi Therapeutics Inc. Stock?
As of the Jun 30, 2026, the market capitalization of Trevi Therapeutics Inc. is 2.648B.

When is the next earnings date for Trevi Therapeutics Inc.?
The upcoming earnings date for Trevi Therapeutics Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT TREVI THERAPEUTICS INC.
Trevi Therapeutics
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo P...
GOLDEN STAR
Ticker Change Signal Date
OSIS
$218.29
0.188% Jun 26
IIIV
$20.09
6.32% Jun 25
JLL
$299.78
3.39% Jun 24
NMRK
$15.02
0.599% Jun 24
X
XMAX
$8.34
8.99% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE